Rheumatoid arthritis in southern Spain: Toward elucidation of a unifying role of the HLA class II region in disease predisposition
Objective To evaluate the contributions of HLA–DQ and –DR polymorphisms to susceptibility to rheumatoid arthritis (RA) in a population in southern Spain, and to compare the value of the shared epitope (SE) and RA protection (RAP) models in accounting for the HLA class II region's contribution t...
Saved in:
Published in | Arthritis and rheumatism Vol. 44; no. 2; pp. 307 - 314 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
John Wiley & Sons, Inc
01.02.2001
Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objective
To evaluate the contributions of HLA–DQ and –DR polymorphisms to susceptibility to rheumatoid arthritis (RA) in a population in southern Spain, and to compare the value of the shared epitope (SE) and RA protection (RAP) models in accounting for the HLA class II region's contribution to RA predisposition.
Methods
One hundred sixty RA patients and 153 healthy controls were typed for HLA–DRB1 and –DQB1 using high‐resolution DNA techniques. Distributions of predisposing DRB1 alleles in patients and control subjects according to the SE model were compared with distributions of predisposing DQ and protective DERAA‐positive DRB1 alleles according to the RAP model.
Results
DQ3 (DQB1*03 and *04 combined with DQA1*03) and DQ5 (DQB1*0501/DQA1*0101) alleles predisposed individuals to RA independently of SE‐positive DRB1 alleles. DQ3/3‐homozygous individuals had the strongest risk of developing RA. DQ3 molecules predisposed to RA more than did DQ5 molecules. The weaker predisposition mediated by DQ5 included the DRB1*1001‐carrying haplotype; no DRB1*1001‐homozygous patients were observed. DRB1*0401 played a unique role in the contribution of DQ3–DR4 haplotypes to RA, in spite of its low frequency in southern Spain.
Conclusion
The low prevalences of RA and of mild disease observed in Spain, and in southern Europe in general, can be explained in great part by the low frequency of DQ3–DR4 haplotypes, especially those carrying DRB1*0401. However, the overall distribution of HLA–DQ and –DR alleles in RA patients compared with control subjects is similar to that in other European and North American populations. A model involving both DQ and DR can best account for the contribution of HLA to RA. |
---|---|
AbstractList | Objective
To evaluate the contributions of HLA–DQ and –DR polymorphisms to susceptibility to rheumatoid arthritis (RA) in a population in southern Spain, and to compare the value of the shared epitope (SE) and RA protection (RAP) models in accounting for the HLA class II region's contribution to RA predisposition.
Methods
One hundred sixty RA patients and 153 healthy controls were typed for HLA–DRB1 and –DQB1 using high‐resolution DNA techniques. Distributions of predisposing DRB1 alleles in patients and control subjects according to the SE model were compared with distributions of predisposing DQ and protective DERAA‐positive DRB1 alleles according to the RAP model.
Results
DQ3 (DQB1*03 and *04 combined with DQA1*03) and DQ5 (DQB1*0501/DQA1*0101) alleles predisposed individuals to RA independently of SE‐positive DRB1 alleles. DQ3/3‐homozygous individuals had the strongest risk of developing RA. DQ3 molecules predisposed to RA more than did DQ5 molecules. The weaker predisposition mediated by DQ5 included the DRB1*1001‐carrying haplotype; no DRB1*1001‐homozygous patients were observed. DRB1*0401 played a unique role in the contribution of DQ3–DR4 haplotypes to RA, in spite of its low frequency in southern Spain.
Conclusion
The low prevalences of RA and of mild disease observed in Spain, and in southern Europe in general, can be explained in great part by the low frequency of DQ3–DR4 haplotypes, especially those carrying DRB1*0401. However, the overall distribution of HLA–DQ and –DR alleles in RA patients compared with control subjects is similar to that in other European and North American populations. A model involving both DQ and DR can best account for the contribution of HLA to RA. To evaluate the contributions of HLA-DQ and -DR polymorphisms to susceptibility to rheumatoid arthritis (RA) in a population in southern Spain, and to compare the value of the shared epitope (SE) and RA protection (RAP) models in accounting for the HLA class II region's contribution to RA predisposition.OBJECTIVETo evaluate the contributions of HLA-DQ and -DR polymorphisms to susceptibility to rheumatoid arthritis (RA) in a population in southern Spain, and to compare the value of the shared epitope (SE) and RA protection (RAP) models in accounting for the HLA class II region's contribution to RA predisposition.One hundred sixty RA patients and 153 healthy controls were typed for HLA-DRB1 and -DQB1 using high-resolution DNA techniques. Distributions of predisposing DRB1 alleles in patients and control subjects according to the SE model were compared with distributions of predisposing DQ and protective DERAA-positive DRBI alleles according to the RAP model.METHODSOne hundred sixty RA patients and 153 healthy controls were typed for HLA-DRB1 and -DQB1 using high-resolution DNA techniques. Distributions of predisposing DRB1 alleles in patients and control subjects according to the SE model were compared with distributions of predisposing DQ and protective DERAA-positive DRBI alleles according to the RAP model.DQ3 (DQBI*03 and *04 combined with DQA1*03) and DQ5 (DQB1*0501/DQA1*0101) alleles predisposed individuals to RA independently of SE-positive DRB1 alleles. DQ3/3-homozygous individuals had the strongest risk of developing RA. DQ3 molecules predisposed to RA more than did DQ5 molecules. The weaker predisposition mediated by DQ5 included the DRB1*1001-carrying haplotype; no DRB1*1001-homozygous patients were observed. DRBI*0401 played a unique role in the contribution of DQ3-DR4 haplotypes to RA, in spite of its low frequency in southern Spain.RESULTSDQ3 (DQBI*03 and *04 combined with DQA1*03) and DQ5 (DQB1*0501/DQA1*0101) alleles predisposed individuals to RA independently of SE-positive DRB1 alleles. DQ3/3-homozygous individuals had the strongest risk of developing RA. DQ3 molecules predisposed to RA more than did DQ5 molecules. The weaker predisposition mediated by DQ5 included the DRB1*1001-carrying haplotype; no DRB1*1001-homozygous patients were observed. DRBI*0401 played a unique role in the contribution of DQ3-DR4 haplotypes to RA, in spite of its low frequency in southern Spain.The low prevalences of RA and of mild disease observed in Spain, and in southern Europe in general, can be explained in great part by the low frequency of DQ3-DR4 haplotypes, especially those carrying DRB1*0401. However, the overall distribution of HLA-DQ and -DR alleles in RA patients compared with control subjects is similar to that in other European and North American populations. A model involving both DQ and DR can best account for the contribution of HLA to RA.CONCLUSIONThe low prevalences of RA and of mild disease observed in Spain, and in southern Europe in general, can be explained in great part by the low frequency of DQ3-DR4 haplotypes, especially those carrying DRB1*0401. However, the overall distribution of HLA-DQ and -DR alleles in RA patients compared with control subjects is similar to that in other European and North American populations. A model involving both DQ and DR can best account for the contribution of HLA to RA. To evaluate the contributions of HLA-DQ and -DR polymorphisms to susceptibility to rheumatoid arthritis (RA) in a population in southern Spain, and to compare the value of the shared epitope (SE) and RA protection (RAP) models in accounting for the HLA class II region's contribution to RA predisposition. One hundred sixty RA patients and 153 healthy controls were typed for HLA-DRB1 and -DQB1 using high-resolution DNA techniques. Distributions of predisposing DRB1 alleles in patients and control subjects according to the SE model were compared with distributions of predisposing DQ and protective DERAA-positive DRBI alleles according to the RAP model. DQ3 (DQBI*03 and *04 combined with DQA1*03) and DQ5 (DQB1*0501/DQA1*0101) alleles predisposed individuals to RA independently of SE-positive DRB1 alleles. DQ3/3-homozygous individuals had the strongest risk of developing RA. DQ3 molecules predisposed to RA more than did DQ5 molecules. The weaker predisposition mediated by DQ5 included the DRB1*1001-carrying haplotype; no DRB1*1001-homozygous patients were observed. DRBI*0401 played a unique role in the contribution of DQ3-DR4 haplotypes to RA, in spite of its low frequency in southern Spain. The low prevalences of RA and of mild disease observed in Spain, and in southern Europe in general, can be explained in great part by the low frequency of DQ3-DR4 haplotypes, especially those carrying DRB1*0401. However, the overall distribution of HLA-DQ and -DR alleles in RA patients compared with control subjects is similar to that in other European and North American populations. A model involving both DQ and DR can best account for the contribution of HLA to RA. |
Author | Caballero, A. Martín, J. Alonso, A. Pascual, M. Matarán, L. Zanelli, E. Nieto, A. López‐Nevot, M. A. Ramal, L. |
Author_xml | – sequence: 1 givenname: M. surname: Pascual fullname: Pascual, M. – sequence: 2 givenname: A. surname: Nieto fullname: Nieto, A. – sequence: 3 givenname: M. A. surname: López‐Nevot fullname: López‐Nevot, M. A. – sequence: 4 givenname: L. surname: Ramal fullname: Ramal, L. – sequence: 5 givenname: L. surname: Matarán fullname: Matarán, L. – sequence: 6 givenname: A. surname: Caballero fullname: Caballero, A. – sequence: 7 givenname: A. surname: Alonso fullname: Alonso, A. – sequence: 8 givenname: J. surname: Martín fullname: Martín, J. – sequence: 9 givenname: E. surname: Zanelli fullname: Zanelli, E. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=930111$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/11229460$$D View this record in MEDLINE/PubMed |
BookMark | eNqVkc9v0zAUgC00xLrBv4AsISF2SHm2kzruEFJVfqxaRcUYZ8tJXlajNA52oqnX_eU4tIwLF062n773HfydkZPWtUiIZDBlAPwty7hKgAn2hgMw4BdpOufvBMj5fLH6kCy-3KTyvZjCdLm55Mn1EzJ53DghEwBIE5EpdkrOQvgRn1xk4hk5ZYxzlc5gQh5utjjsTO9sRY3vt972NlDb0uCGfou-pd86Y9s5vXX3xlcUm6G0lemta6mrqaFDa-u9be-odw2Oo7hFr9YLWjYmBLpaUY93Ix2dlQ1oAtLOY7x2LtjR85w8rU0T8MXxPCffP328XV4l683n1XKxTkquZjLBQiBiUbEyg1KirPK8YJAKlXPBwOR5VoNQRZ4JY1glISv4TBSpUspUuRBSnJPXB2_n3c8BQ693NpTYNKZFNwQtYSYUlzyCL4_gUOyw0p23O-P3-s-vReDVETChNE3tTVva8MgpAYyxSG0OVOldCB7rvyLQY109ttJjK32oq9NUcx3rah3r6t91tdCgl5s4v47GrwfjvW1w_x-6f9kOA_ELmhKzjA |
CODEN | ARHEAW |
Cites_doi | 10.1093/rheumatology/37.2.165 10.1038/nm0396-306 10.1111/j.1399-0039.1994.tb02347.x 10.1046/j.1365-2370.1999.00135.x 10.1002/art.1780310302 10.1016/0167-5699(95)80181-2 10.1002/art.1780350306 10.1093/intimm/8.5.757 10.1084/jem.180.4.1559 10.1172/JCI108382 10.1002/eji.1830270634 10.1002/art.1780301102 10.1016/S0198-8859(98)00101-3 10.1111/j.1399-0039.1994.tb02291.x 10.1093/rheumatology/36.3.322 10.1073/pnas.93.5.1814 10.1016/S0065-2776(08)60456-3 10.1136/ard.40.3.299 10.1080/03009749850154447 10.1007/s002510050450 10.1002/art.1780350705 10.1136/bmj.283.6302.1287 10.1093/rheumatology/39.8.844 10.1002/art.1780340107 10.1084/jem.183.1.27 10.1016/S0198-8859(99)00059-2 10.1016/S0889-857X(21)00149-6 10.1111/j.1399-0039.1990.tb01825.x 10.1016/0198-8859(95)00165-4 10.1016/S0065-2776(08)60563-5 10.1111/j.1399-0039.1996.tb02515.x 10.1002/art.1780370125 |
ContentType | Journal Article |
Copyright | Copyright © 2001 by the American College of Rheumatology 2001 INIST-CNRS |
Copyright_xml | – notice: Copyright © 2001 by the American College of Rheumatology – notice: 2001 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1529-0131 |
EndPage | 314 |
ExternalDocumentID | 11229460 930111 10_1002_1529_0131_200102_44_2_307__AID_ANR47_3_0_CO_2_K ANR47 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Europe Spain |
GeographicLocations_xml | – name: Spain |
GrantInformation_xml | – fundername: Plan Andaluz de Investigación funderid: CTS‐180 – fundername: Plan Nacional de I+D (CICYT) funderid: SAF97‐0046; SAF00‐213 |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 10A 1CY 1KJ 1L6 1OB 1OC 1ZS 23N 24P 31~ 33P 3O- 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52W 52X 53G 5GY 5RE 66C 6J9 6P2 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAQQT AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACMXC ACPOU ACRPL ACSCC ACXBN ACXQS ACYXJ ADBTR ADEOM ADIZJ ADMGS ADNMO ADOZA ADZCM ADZOD AEEZP AEIGN AEIMD AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AI. AIACR AITYG AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZFZN BDRZF BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM EBS EJD EMOBN EX3 F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J5H JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LSO LUTES LW6 LYRES M65 MEWTI MJL MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NNB OIG OK1 OVD P2P P2W P2X P2Z P4B P4D Q11 QB0 QRW RGB RIWAO RJQFR ROL RWI RX1 RXW RYL SAMSI SJN SUPJJ SV3 TAE TEORI TWZ UB1 V2E V8K V9Y VH1 W8V WH7 WIB WIH WIJ WIK WIN WJL WOW WQJ WRC WUP WXI WXSBR X6Y X7M XG1 XPP XV2 YFH YOC ZGI ZXP ZZTAW ~IA ~WT AAFWJ AAYXX AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY IQODW CGR CUY CVF ECM EIF NPM VXZ 7X8 |
ID | FETCH-LOGICAL-c2967-eb3eeebd1c50c7e7d88b1043982310a885f039b853aa1d705b263b4999ad83373 |
IEDL.DBID | DR2 |
ISSN | 0004-3591 |
IngestDate | Thu Jul 10 22:36:27 EDT 2025 Wed Feb 19 01:28:43 EST 2025 Mon Jul 21 09:12:11 EDT 2025 Tue Jul 01 02:40:35 EDT 2025 Wed Jan 22 16:48:51 EST 2025 |
IsPeerReviewed | false |
IsScholarly | false |
Issue | 2 |
Keywords | Human Immunopathology HLA-System Pathogenesis Diseases of the osteoarticular system Class II histocompatibility antigen Autoimmune disease Exploration Inflammatory joint disease Genetic determinism Epidemiology Symptomatology Chronic DNA Rheumatoid arthritis Public health Polymorphism |
Language | English |
License | http://doi.wiley.com/10.1002/tdm_license_1.1 CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2967-eb3eeebd1c50c7e7d88b1043982310a885f039b853aa1d705b263b4999ad83373 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 11229460 |
PQID | 70639272 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_70639272 pubmed_primary_11229460 pascalfrancis_primary_930111 crossref_primary_10_1002_1529_0131_200102_44_2_307__AID_ANR47_3_0_CO_2_K wiley_primary_10_1002_1529_0131_200102_44_2_307_AID_ANR47_3_0_CO_2_K_ANR47 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | February 2001 |
PublicationDateYYYYMMDD | 2001-02-01 |
PublicationDate_xml | – month: 02 year: 2001 text: February 2001 |
PublicationDecade | 2000 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: Hoboken , NJ – name: United States |
PublicationTitle | Arthritis and rheumatism |
PublicationTitleAlternate | Arthritis Rheum |
PublicationYear | 2001 |
Publisher | John Wiley & Sons, Inc Wiley |
Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley |
References | 1998; 27 1998; 48 1981; 283 1987; 30 1990; 36 1991; 34 1995; 16 1999; 26 1992; 18 1996; 183 1996; 93 1992; 19 1997; 27 1992; 35 1988; 31 1999; 60 1981; 40 1994; 43 1992; 96 1998; 68 1998; 37 1976; 57 2000; 39 1994; 180 1997; 36 1995; 22 1994; 56 1994; 37 1996; 47 1996; 46 1996; 2 1996; 8 Seidl (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB28) 1999; 26 Maffei (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB33) 1997; 27 Arnett (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB24) 1988; 31 Van der Horst-Bruinsma (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB18) 1999; 60 Das (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB17) 1999; 60 Nepom (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB32) 1998; 68 Willkens (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB11) 1991; 34 Boey (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB8) 1992; 19 Auger (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB36) 1996; 2 Zanelli (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB13) 1995; 16 Wakitani (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB29) 1998; 27 Taneja (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB25) 1996; 46 Ronda (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB19) 1994; 37 Taneja (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB6) 1992; 96 Svejgaard (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB27) 1994; 43 Matsushita (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB34) 1996; 8 Winchester (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB2) 1994; 56 Nabozny (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB15) 1996; 183 Gregersen (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB9) 1987; 30 Gonzalez-Gay (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB12) 1994; 180 Ollier (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB1) 1992; 18 Zanelli (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB16) 1996; 93 Sanchez (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB10) 1990; 36 Stastny (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB3) 1976; 57 Maeda (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB7) 1981; 40 Zanelli (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB14) 1998; 48 Benazet (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB22) 1995; 22 Stavropoulos-Giokas (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB31) 1999; 60 McDonagh (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB35) 1997; 36 Woodrow (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB4) 1981; 283 González (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB30) 1992; 35 Balsa (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB23) 2000; 39 De Juan (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB5) 1994; 43 Martinez-Laso (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB26) 1996; 47 Salvarani (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB20) 1998; 37 Drosos (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB21) 1992; 35 |
References_xml | – volume: 48 start-page: 394 year: 1998 end-page: 401 article-title: An extended HLA‐DQ‐DR haplotype rather than DRB1 alone contributes to RA predisposition publication-title: Immunogenetics – volume: 40 start-page: 299 year: 1981 end-page: 302 article-title: HLA‐DR4 and rheumatoid arthritis in Japanese people publication-title: Ann Rheum Dis – volume: 68 start-page: 315 year: 1998 end-page: 32 article-title: Major histocompatibility complex‐directed susceptibility to rheumatoid arthritis publication-title: Adv Immunol – volume: 60 start-page: 152 year: 1999 end-page: 8 article-title: HLA‐DQ‐associated predisposition to and dominant HLA‐DR‐associated protection against rheumatoid arthritis publication-title: Hum Immunol – volume: 31 start-page: 315 year: 1988 end-page: 24 article-title: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis publication-title: Arthritis Rheum – volume: 60 start-page: 575 year: 1999 end-page: 82 article-title: An HLA‐DRB1*0402 derived peptide (HV3 65‐79) prevents collagen‐induced arthritis in HLA‐DQ8 transgenic mice publication-title: Hum Immunol – volume: 183 start-page: 27 year: 1996 end-page: 37 article-title: HLA‐DQ8 transgenic mice are highly susceptible to collagen‐induced arthritis: a novel model for human polyarthritis publication-title: J Exp Med – volume: 36 start-page: 322 year: 1997 end-page: 7 article-title: Compound heterozygosity for the shared epitope and the risk and severity of rheumatoid arthritis in extended pedigrees publication-title: Br J Rheumatol – volume: 2 start-page: 306 year: 1996 end-page: 10 article-title: HLA‐DR4 and HLA‐DR10 motifs that carry susceptibility to rheumatoid arthritis bind 70‐kD heat shock proteins publication-title: Nat Med – volume: 19 start-page: 1517 year: 1992 end-page: 9 article-title: HLA in Singapore Chinese with rheumatoid arthritis publication-title: J Rheumatol – volume: 57 start-page: 1148 year: 1976 end-page: 57 article-title: Mixed lymphocyte cultures in rheumatoid arthritis publication-title: J Clin Invest – volume: 35 start-page: 282 year: 1992 end-page: 9 article-title: Novel genetic markers of rheumatoid arthritis in Chilean patients, by DR serotyping and restriction fragment length polymorphism analysis publication-title: Arthritis Rheum – volume: 27 start-page: 381 year: 1998 end-page: 2 article-title: The homozygote of HLA‐DRB1*0901, not its heterozygote, is associated with rheumatoid arthritis in Japanese publication-title: Scand J Rheumatol – volume: 18 start-page: 741 year: 1992 end-page: 59 article-title: Population genetics of rheumatoid arthritis publication-title: Rheum Dis Clin North Am – volume: 35 start-page: 745 year: 1992 end-page: 8 article-title: Rheumatoid arthritis in Greek and British patients: a comparative clinical, radiologic, and serologic study publication-title: Arthritis Rheum – volume: 37 start-page: 165 year: 1998 end-page: 9 article-title: HLA‐DRB1 alleles associated with rheumatoid arthritis in northern Italy: correlation with disease severity publication-title: Br J Rheumatol – volume: 43 start-page: 18 year: 1994 end-page: 27 article-title: HLA and disease associations: detecting the strongest association publication-title: Tissue Antigens – volume: 60 start-page: S48 issue: Suppl 1 year: 1999 article-title: The shared epitope versus DR/DQ haplotype hypothesis in rheumatoid arthritis in Greeks publication-title: Hum Immunol – volume: 26 start-page: 19 year: 1999 end-page: 27 article-title: HLA‐DR/DQ interaction in patients with erosive rheumatoid arthritis presenting articular and extraarticular disease manifestations publication-title: Eur J Immunogenet – volume: 180 start-page: 1559 year: 1994 end-page: 64 article-title: Protective role of major histocompatibility complex class II Eb transgene on collagen‐induced arthritis publication-title: J Exp Med – volume: 37 start-page: 147 year: 1994 end-page: 8 article-title: Differences between Spanish and British patients in the severity of rheumatoid arthritis: comment on the article by Drosos et al publication-title: Arthritis Rheum – volume: 16 start-page: 274 year: 1995 end-page: 8 article-title: Could HLA‐DRB1 be the protective locus in rheumatoid arthritis? publication-title: Immunol Today – volume: 39 start-page: 844 year: 2000 end-page: 9 article-title: Class II MHC antigens in early rheumatoid arthritis in Bath (UK) and Madrid (Spain) publication-title: Rheumatology – volume: 34 start-page: 43 year: 1991 end-page: 7 article-title: Association of HLA–Dw16 with rheumatoid arthritis in Yakima Indians: further evidence for the “shared epitope” hypothesis publication-title: Arthritis Rheum – volume: 30 start-page: 1205 year: 1987 end-page: 13 article-title: The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis publication-title: Arthritis Rheum – volume: 36 start-page: 174 year: 1990 end-page: 6 article-title: HLA‐DRw10 confers the highest susceptibility to rheumatoid arthritis in a Spanish population publication-title: Tissue Antigens – volume: 27 start-page: 1549 year: 1997 end-page: 56 article-title: Differential expression of insulin‐dependent diabetes mellitus‐associated HLA‐DQA1 alleles in vivo publication-title: Eur J Immunol – volume: 8 start-page: 757 year: 1996 end-page: 64 article-title: HLA‐DQ‐binding peptide motifs: comparative binding analysis of type II collagen‐derived peptides to DR and DQ molecules of rheumatoid arthritis‐susceptible and non‐susceptible haplotypes publication-title: Int Immunol – volume: 93 start-page: 1814 year: 1996 end-page: 9 article-title: Immune response of HLA‐DQ8 transgenic mice to peptides from the third hypervariable region of HLA‐DRB1 correlates with predisposition to rheumatoid arthritis publication-title: Proc Natl Acad Sci U S A – volume: 47 start-page: 63 year: 1996 end-page: 71 article-title: HLA‐DR and DQ polymorphism in Ashkenazi and non‐Ashkenazi Jews: comparison with other Mediterraneans publication-title: Tissue Antigens – volume: 56 start-page: 389 year: 1994 end-page: 466 article-title: The molecular basis of susceptibility to rheumatoid arthritis publication-title: Adv Immunol – volume: 22 start-page: 607 year: 1995 end-page: 10 article-title: HLA‐DRB1 alleles associated with rheumatoid arthritis in southern France: absence of extraarticular disease despite expression of the shared epitope publication-title: J Rheumatol – volume: 96 start-page: 16 year: 1992 end-page: 23 article-title: Protective & risk DR phenotypes in Asian Indian patients with rheumatoid arthritis publication-title: Indian J Med Res – volume: 43 start-page: 320 year: 1994 end-page: 3 article-title: Differential association with rheumatoid arthritis (RA) in Basques: high frequency of DR1 and DR10 and lack of association with HLA‐DR4 or any of its subtypes publication-title: Tissue Antigens – volume: 46 start-page: 35 year: 1996 end-page: 41 article-title: Polymorphism of HLA‐DRB, ‐DQA1, and ‐DQB1 in rheumatoid arthritis in Asian Indians: association with DRB1*0405 and DRB1*1001 publication-title: Hum Immunol – volume: 283 start-page: 1287 year: 1981 end-page: 8 article-title: DR antigens and rheumatoid arthritis: a study in two populations publication-title: Br Med J – volume: 96 start-page: 16 year: 1992 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB6 publication-title: Indian J Med Res – volume: 37 start-page: 165 year: 1998 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB20 publication-title: Br J Rheumatol doi: 10.1093/rheumatology/37.2.165 – volume: 2 start-page: 306 year: 1996 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB36 publication-title: Nat Med doi: 10.1038/nm0396-306 – volume: 43 start-page: 320 year: 1994 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB5 publication-title: Tissue Antigens doi: 10.1111/j.1399-0039.1994.tb02347.x – volume: 26 start-page: 19 year: 1999 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB28 publication-title: Eur J Immunogenet doi: 10.1046/j.1365-2370.1999.00135.x – volume: 31 start-page: 315 year: 1988 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB24 publication-title: Arthritis Rheum doi: 10.1002/art.1780310302 – volume: 16 start-page: 274 year: 1995 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB13 publication-title: Immunol Today doi: 10.1016/0167-5699(95)80181-2 – volume: 22 start-page: 607 year: 1995 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB22 publication-title: J Rheumatol – volume: 35 start-page: 282 year: 1992 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB30 publication-title: Arthritis Rheum doi: 10.1002/art.1780350306 – volume: 60 start-page: s48 year: 1999 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB31 publication-title: Hum Immunol – volume: 8 start-page: 757 year: 1996 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB34 publication-title: Int Immunol doi: 10.1093/intimm/8.5.757 – volume: 180 start-page: 1559 year: 1994 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB12 publication-title: J Exp Med doi: 10.1084/jem.180.4.1559 – volume: 57 start-page: 1148 year: 1976 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB3 publication-title: J Clin Invest doi: 10.1172/JCI108382 – volume: 27 start-page: 1549 year: 1997 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB33 publication-title: Eur J Immunol doi: 10.1002/eji.1830270634 – volume: 30 start-page: 1205 year: 1987 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB9 publication-title: Arthritis Rheum doi: 10.1002/art.1780301102 – volume: 60 start-page: 152 year: 1999 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB18 publication-title: Hum Immunol doi: 10.1016/S0198-8859(98)00101-3 – volume: 43 start-page: 18 year: 1994 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB27 publication-title: Tissue Antigens doi: 10.1111/j.1399-0039.1994.tb02291.x – volume: 36 start-page: 322 year: 1997 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB35 publication-title: Br J Rheumatol doi: 10.1093/rheumatology/36.3.322 – volume: 93 start-page: 1814 year: 1996 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB16 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.93.5.1814 – volume: 56 start-page: 389 year: 1994 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB2 publication-title: Adv Immunol doi: 10.1016/S0065-2776(08)60456-3 – volume: 40 start-page: 299 year: 1981 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB7 publication-title: Ann Rheum Dis doi: 10.1136/ard.40.3.299 – volume: 27 start-page: 381 year: 1998 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB29 publication-title: Scand J Rheumatol doi: 10.1080/03009749850154447 – volume: 48 start-page: 394 year: 1998 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB14 publication-title: Immunogenetics doi: 10.1007/s002510050450 – volume: 35 start-page: 745 year: 1992 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB21 publication-title: Arthritis Rheum doi: 10.1002/art.1780350705 – volume: 283 start-page: 1287 year: 1981 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB4 publication-title: Br Med J doi: 10.1136/bmj.283.6302.1287 – volume: 39 start-page: 844 year: 2000 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB23 publication-title: Rheumatology doi: 10.1093/rheumatology/39.8.844 – volume: 34 start-page: 43 year: 1991 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB11 publication-title: Arthritis Rheum doi: 10.1002/art.1780340107 – volume: 183 start-page: 27 year: 1996 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB15 publication-title: J Exp Med doi: 10.1084/jem.183.1.27 – volume: 60 start-page: 575 year: 1999 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB17 publication-title: Hum Immunol doi: 10.1016/S0198-8859(99)00059-2 – volume: 18 start-page: 741 year: 1992 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB1 publication-title: Rheum Dis Clin North Am doi: 10.1016/S0889-857X(21)00149-6 – volume: 36 start-page: 174 year: 1990 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB10 publication-title: Tissue Antigens doi: 10.1111/j.1399-0039.1990.tb01825.x – volume: 46 start-page: 35 year: 1996 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB25 publication-title: Hum Immunol doi: 10.1016/0198-8859(95)00165-4 – volume: 68 start-page: 315 year: 1998 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB32 publication-title: Adv Immunol doi: 10.1016/S0065-2776(08)60563-5 – volume: 47 start-page: 63 year: 1996 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB26 publication-title: Tissue Antigens doi: 10.1111/j.1399-0039.1996.tb02515.x – volume: 37 start-page: 147 year: 1994 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB19 publication-title: Arthritis Rheum doi: 10.1002/art.1780370125 – volume: 19 start-page: 1517 year: 1992 ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB8 publication-title: J Rheumatol |
SSID | ssj0002353 |
Score | 1.3693492 |
Snippet | Objective
To evaluate the contributions of HLA–DQ and –DR polymorphisms to susceptibility to rheumatoid arthritis (RA) in a population in southern Spain, and... To evaluate the contributions of HLA-DQ and -DR polymorphisms to susceptibility to rheumatoid arthritis (RA) in a population in southern Spain, and to compare... |
SourceID | proquest pubmed pascalfrancis crossref wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 307 |
SubjectTerms | Alleles Arthritis, Rheumatoid - epidemiology Arthritis, Rheumatoid - genetics Biological and medical sciences Diseases of the osteoarticular system Female Genetic Predisposition to Disease Histocompatibility Antigens Class II - genetics HLA-DQ Antigens - genetics HLA-DR Antigens - genetics HLA-DR Serological Subtypes HLA-DR1 Antigen - genetics HLA-DR4 Antigen - genetics Humans Inflammatory joint diseases Linkage Disequilibrium Male Medical sciences Middle Aged Spain - epidemiology |
Title | Rheumatoid arthritis in southern Spain: Toward elucidation of a unifying role of the HLA class II region in disease predisposition |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2F1529-0131%28200102%2944%3A2%3C307%3A%3AAID-ANR47%3E3.0.CO%3B2-K https://www.ncbi.nlm.nih.gov/pubmed/11229460 https://www.proquest.com/docview/70639272 |
Volume | 44 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1Lb9QwELaqHiokxPsRKOADleCQbWI7rwUhLUur3Za20tJKvVm246gRKFm6mwtHfgK_mJk42dWiXpAQx1iJx5qHPY4_f0PI6zhjoYVU19dYKEwYW_jKxJkfFJZpo62OA7yNfHIaTy7E0WV0uUW-93dhHD_E6ocbRkY7X2OAK73YX5OGwsKDSB8OAZ-ylhoN9s5CgGHZHh8jvJnjL-rR9JM_Op0JeDzgg2AwPtvjH5l_DLM2IrwwjZqtCacY73gr8bwgysIdknQS91fy3jhpb4UYsvcgZzhcyfjgJLyD_jfWudtztQCVF65Wxk3J7GZu3C5uh3fJr14tDtPyddAs9cD8-IMx8r_q7R6506XKdOR8-z7ZstUDsnPSgQEekp-zK9tAwl2XOYUAuGrpmWhZ0UXdwvYr-mWuympIz1toMLXfGlO6ElK0LqiiTVW2t7woQiyxCb6ik88janBLQadTimUr4G3oszvIovNrvMjcQ90ekYvDg_PxxO9KSviGZbAkWM2ttToPTRSYxCZ5muoQbwfjaWig0jQqAp5pyGGUCvMkiDSLucZdocpTzhP-mGxXdWWfElqkIsuRLS3PmTCF0DrJlI21MirOQ5V5ZNI7gJw75hDpOKKZRBtItIF0FpBCSCZB91KC3mWrd8llIMdn0H7skd0NB1r1l-H0HHrkVe9PEiYHPPFRla2bhUwwAWUJ88gT52brkYQMrB4HHjlqneUvhnjTCF3Ds3_Z2XNyy-H9EDq0S7aX1419AQngUr9sY_Y3vy49Pw |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1LaxsxEBZpCmmh9P1wmzY6NNAe1tmV5H24peA6CXb8CDgO5CYkrZaYhLWxvZce-xf6hzuzWtu45FIoPVp4NWIe0kj69A0hH8OEBRZSXU9joTBhbOYpEyaen1mmjbY69PE18mAYdi7F2VXjaofMV29hHD_E-sANI6OcrzHA8UD6aMMaCisPQn04RHzMSm402DwLAZZlh7yN-GaOZ9St7rHXGo4E_Dzhdb_ePj_k35nXu0fuYx1w5Ns_Hm0opxivmCvxxqCRBHskqkQerQV-cuI-C9FkX0FQs7kW8s2J-AICtla6RzO1AKVnrlrGXensdnZcLm-nT8ivlWIcquWmXix13fz4gzPy_2ruKXlcZcu05dz7Gdmx-XOyN6jwAC_Iz9G1LSDnnk5SCjFwXTI00UlOF9MSuZ_Ti5ma5E06LtHB1N4WZuKqSNFpRhUt8kn50IsiyhKb4Cva6beowV0F7XYpVq6Af0Of1V0Wnc3xLfMK7faSXJ6ejNsdr6oq4RmWwKpgNbfW6jQwDd9ENkrjWAf4QBgvRH0Vx43M54mGNEapII38hmYh17gxVGnMecRfkd18mts3hGaxSFIkTEtTJkwmtI4SZUOtjArTQCU10ll5gJw58hDpaKKZRBtItIF0FpBCSCZB91KC3mWpd8mlL9vn0N6rkf0tD1r3l-AMHdTIwcqhJMwPeOmjcjstFjLCHJRFrEZeOz_bjCRgYPXQr5Gz0lv-Yoh3jdA1vP2XnR2QB53xoC_73WHvHXno4H-IJNonu8t5Yd9DPrjUH8oA_g2w30Fb |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1bb9MwFLbGkCokxP1SGMwPTIKHdInt5lIQUmlXtevWobJJe7Nsx9EqUFLW5oVHfgK_mHPitFXRXpAQj7ESH-tc7OP483cIeRMmLLCQ6noaC4UJYzNPmTDx_MwybbTVoY-3kU8n4fBCHF-2L3fI99VdGMcPsf7hhpFRzdcY4PM0O9yQhsLCg0gfDgEfs4oaDfbOQoBh2QHvIbyZ4y_q7qjvdSdTAY9HvOW3emcH_BPzxrfIbRH6CVZ76E83jFOM18SVeGDQToIGiWqRh2uBb524d0J02AcQ1OmshXx0It6DgK2F7u5cLUDnmSuWcVM2u50cV6vb4D75tdKLA7V8bZVL3TI__qCM_K-Ke0Du1bky7Trnfkh2bP6INE5rNMBj8nN6ZUvIuItZSiECrip-JjrL6aKocPs5_TJXs7xDzytsMLXfSjNzNaRokVFFy3xWXfOiiLHEJviKDk-61OCego5GFOtWwNvQZ32SRefXeJN5hXV7Qi4GR-e9oVfXlPAMS2BNsJpba3UamLZvIhulcawDvB6Mx6G-iuN25vNEQxKjVJBGfluzkGvcFqo05jziT8luXuT2OaFZLJIU6dLSlAmTCa2jRNlQK6PCNFBJkwxXDiDnjjpEOpJoJtEGEm0gnQWkEJJJ0L2UoHdZ6V1y6cveGbSPm2Rvy4HW_SU4PwdNsr_yJwmzAx75qNwW5UJGmIGyiDXJM-dmm5EEDKwe-k1yXDnLXwzxphG6hhf_srN90vjcH8iT0WT8ktxx2D-EEe2R3eV1aV9BMrjUr6vw_Q2LU0AK |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rheumatoid+arthritis+in+southern+Spain%3A+toward+elucidation+of+a+unifying+role+of+the+HLA+class+II+region+in+disease+predisposition&rft.jtitle=Arthritis+and+rheumatism&rft.au=Pascual%2C+M&rft.au=Nieto%2C+A&rft.au=L%C3%B3pez-Nevot%2C+M+A&rft.au=Ramal%2C+L&rft.date=2001-02-01&rft.issn=0004-3591&rft.volume=44&rft.issue=2&rft.spage=307&rft_id=info:doi/10.1002%2F1529-0131%28200102%2944%3A2%3C307%3A%3AAID-ANR47%3E3.0.CO%3B2-K&rft_id=info%3Apmid%2F11229460&rft.externalDocID=11229460 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0004-3591&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0004-3591&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0004-3591&client=summon |